Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC)

Results of a phase II study

Cited in:

CrossRef

This article has been cited by:

1. 1
   Rangaswamy Govindarajan, Eric Siegel, Issam Makhoul, Stephen Williamson, Bevacizumab and Erlotinib in Previously Untreated Inoperable and Metastatic Hepatocellular Carcinoma, American Journal of Clinical Oncology, 2013, 36, 3, 254

   CrossRef

2. 2
   Marion Dhooge, Romain Coriat, Olivier Mir, Géraldine Perkins, Catherine Brezault, Pascaline Boudou-Rouquette, François Goldwasser, Stanislas Chaussade, Feasibility of Gemcitabine plus Oxaliplatin in Advanced Hepatocellular Carcinoma Patients with Child-Pugh B Cirrhosis, Oncology, 2013, 84, 1, 32

   CrossRef

3. 3
   Aziz Zaanan, Nicolas Williet, Mohamed Hebbar, Tienhan Sandrine Dabakuyo, Laetitia Fartoux, Touraj Mansourbakht, Olivier Dubreuil, Olivier Rosmorduc, Stéphane Cattan, Franck Bonnetain, Valérie Boige, Julien Taïeb, Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: A large multicenter AGEO study, Journal of Hepatology, 2013, 58, 1, 81

   CrossRef

4. 4
   Monica Dandona Desai, Bikramajit Singh Saroya, Albert Craig Lockhart, Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers, Expert Opinion on Investigational Drugs, 2013, 22, 3, 341

   CrossRef

5. 5
   Uzma Asghar, Tim Meyer, Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?, Journal of Hepatology, 2012, 56, 3, 686

   CrossRef

6. 6
   Hua Zhu, Ping Sun, Clinical study of FOLFOX4 regimen for patients of advanced hepatocellular carcinoma, The Chinese-German Journal of Clinical Oncology, 2012, 11, 3, 134

   CrossRef

7. 7
   Romain Coriat, Olivier Mir, Anatole Cessot, Catherine Brezault, Stanislas Ropert, Jean-Philippe Durand, Wulfran Cacheux, Stanislas Chaussade, François Goldwasser, Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients, Investigational New Drugs, 2012, 30, 1, 376

   CrossRef

8. 8
   Steven R. Alberts, Joel M. Reid, Bruce W. Morlan, Gist H. Farr, John K. Camoriano, David B. Johnson, James R. Enger, Thomas E. Seay, George P. Kim, Gemcitabine and Docetaxel for Hepatocellular Carcinoma, American Journal of Clinical Oncology, 2012, 35, 5, 418

   CrossRef

9. 9
   Olivier Mir, Romain Coriat, Pascaline Boudou-Rouquette, Stanislas Ropert, Jean-Philippe Durand, Anatole Cessot, Vincent Mallet, Philippe Sogni, Stanislas Chaussade, Stanislas Pol, François Goldwasser, Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib, Medical Oncology, 2012, 29, 4, 2793

   CrossRef

10. 10
    Jean-Philippe Spano, Y. Vano, S. Vignot, T. La Motte Rouge, L. Hassani, R. Mouawad, F. Menegaux, D. Khayat, L. Leenhardt, GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma, Medical Oncology, 2012, 29, 3, 1421

    CrossRef

11. 11
    C. Verslype, O. Rosmorduc, P. Rougier, Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, 2012, 23, suppl 7, vii41

    CrossRef

12. 12
    Chin-Sheng Hung, Shen-Fu Lin, Hui-Hsiung Liu, Li-Jen Kuo, Li-Tzu Li, Hou-Yu Su, Phui-Ly Liew, Feng-Yen Lin, Po-Li Wei, Der-Zen Liu, Yu-Jia Chang, Survivin-mediated Therapeutic Efficacy of Gemcitabine through Glucose-regulated Protein 78 in Hepatocellular Carcinoma, Annals of Surgical Oncology, 2012, 19, 8, 2744

    CrossRef

13. 13
    Davendra P. S. Sohal, Weijing Sun, Hepatocellular Carcinoma: Prevention and Therapy, Current Oncology Reports, 2011, 13, 3, 186

    CrossRef

14. 14
    Giuseppe Lombardi, Fable Zustovich, Fabio Farinati, Umberto Cillo, Alessandro Vitale, Giacomo Zanus, Martin Donach, Miriam Farina, Stefania Zovato, Davide Pastorelli, Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma, Cancer, 2011, 117, 1

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(150K)
    • References
15. 15
    Weijing Sun, Davendra Sohal, Daniel G. Haller, Kristine Mykulowycz, Mark Rosen, Michael C. Soulen, Millie Caparro, Ursina R. Teitelbaum, Bruce Giantonio, Peter J. O'Dwyer, Abraham Shaked, Rajender Reddy, Kim Olthoff, Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma, Cancer, 2011, 117, 14

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(169K)
    • References
16. 16
    P. Merle, F. Mornex, Prise en charge médicale du carcinome hépatocellulaire, Cancer/Radiothérapie, 2011, 15, 1, 28

    CrossRef

17. 17
    A. K. Elpiner, E. M. Brodsky, T. N. Hazzah, G. S. Post, Single-agent gemcitabine chemotherapy in dogs with hepatocellular carcinomas, Veterinary and Comparative Oncology, 2011, 9, 4

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(499K)
    • References
18. 18
    Stephen H. Wrzesinski, Tamar H. Taddei, Mario Strazzabosco, Systemic Therapy in Hepatocellular Carcinoma, Clinics in Liver Disease, 2011, 15, 2, 423

    CrossRef

19. 19
    Hye Ryun KIM, Seong Ha CHEON, Sun Young RHA, Soohyeon LEE, Kwang-Hyub HAN, Chae Yoon CHON, Jong Doo LEE, Jin Sil SUNG, Hyun Cheol CHUNG, Treatment of recurrent hepatocellular carcinoma after liver transplantation, Asia-Pacific Journal of Clinical Oncology, 2011, 7, 3

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(360K)
    • References
20. 20
    T. Takahara, H. Nitta, Y. Hasegawa, N. Itou, M. Takahashi, G. Wakabayashi, Using Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation—Interactions Between Calcineurin Inhibitor: Two Case Reports, Transplantation Proceedings, 2011, 43, 7, 2800

    CrossRef

21. 21
    George Papatsimbas, Christina Chatedaki, Dimitris Zacharoulis, Targeted Therapies for Hepatocellular Carcinoma, 2011,

    CrossRef

22. 22
    Krisztina Hagymási, Zsolt Tulassay, A májsejtrák célzott kezelésének újabb lehetőségei a molekuláris biológiai adatok ismeretében, Orvosi Hetilap, 2010, 151, 43, 1763

    CrossRef

23. 23
    Masao Omata, Laurentius A. Lesmana, Ryosuke Tateishi, Pei-Jer Chen, Shi-Ming Lin, Haruhiko Yoshida, Masatoshi Kudo, Jeong Min Lee, Byung Ihn Choi, Ronnie T. P. Poon, Shuichiro Shiina, Ann Lii Cheng, Ji-Dong Jia, Shuntaro Obi, Kwang Hyub Han, Wasim Jafri, Pierce Chow, Seng Gee Lim, Yogesh K. Chawla, Unggul Budihusodo, Rino A. Gani, C. Rinaldi Lesmana, Terawan Agus Putranto, Yun Fan Liaw, Shiv Kumar Sarin, Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma, Hepatology International, 2010, 4, 2, 439

    CrossRef

24. You have free access to this content24
    Chapter 4: Chemotherapy and radiotherapy, Hepatology Research, 2010, 40,

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(147K)
    • References
25. 25
    Jacqueline Whang-Peng, Ann-Lii Cheng, Chiun Hsu, Chien-Ming Chen, Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma, Journal of Experimental & Clinical Medicine, 2010, 2, 3, 93

    CrossRef

26. 26
    Gilles Boschetti, Thomas Walter, Valérie Hervieu, Philippe Cassier, Catherine Lombard-Bohas, Mustapha Adham, Jean-Yves Scoazec, Jérôme Dumortier, Complete response of hepatocellular carcinoma with systemic combination chemotherapy: not to get out the chemotherapy?, European Journal of Gastroenterology & Hepatology, 2010, 22, 8, 1015

    CrossRef

27. 27
    Austin Duffy, Tim Greten, Developing better treatments in hepatocellular carcinoma, Expert Review of Gastroenterology & Hepatology, 2010, 4, 5, 551

    CrossRef

28. 28
    Yu-Yun SHAO, Chun-Chieh HUANG, Po-Chin LIANG, Zhong-Zhe LIN, Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma, Asia-Pacific Journal of Clinical Oncology, 2010, 6, 2

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(118K)
    • References
29. 29
    Charles H. Cha, M. Wasif Saif, Brett H. Yamane, Sharon M. Weber, Hepatocellular Carcinoma: Current Management, Current Problems in Surgery, 2010, 47, 1, 10

    CrossRef

30. 30
    Ritesh Rathore, Howard Safran, Greg Soares, Greg Dubel, Brendan McNulty, Sun Ahn, David Iannitti, Teresa Kennedy, Phase I Study of Hepatic Arterial Infusion of Oxaliplatin in Advanced Hepatocellular Cancer, American Journal of Clinical Oncology, 2010, 33, 1, 43

    CrossRef

31. 31
    Abby B. Siegel, Sonja K. Olsen, Arthur Magun, Robert S. Brown, Sorafenib: Where do we go from here?, Hepatology, 2010, 52, 1

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(331K)
    • References
32. 32
    Andrew X. Zhu, Systemic Treatment of Hepatocellular Carcinoma: Dawn of a New Era?, Annals of Surgical Oncology, 2010, 17, 5, 1247

    CrossRef

33. 33
    Lorenza Rimassa, Armando Santoro, The present and the future landscape of treatment of advanced hepatocellular carcinoma, Digestive and Liver Disease, 2010, 42, S273

    CrossRef

34. 34
    S. Pesque, T. Baere, V. Boige, Traitements du carcinome hépatocellulaire non accessible à un traitement curatif: actualités, Oncologie, 2010, 12, 10, 615

    CrossRef

35. 35
    Sung-Chul Lim, Jeong Eun Choi, Ho Sung Kang, Han SI, Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma, International Journal of Cancer, 2010, 126, 7

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(641K)
    • References
36. 36
    Ji Eun Uhm, Joon Oh Park, Jeeyun Lee, Young Suk Park, Se Hoon Park, Byung Chul Yoo, Seung Woon Paik, Kwang Cheol Koh, Won Ki Kang, Ho Yeong Lim, A phase II study of oxaliplatin in combination with doxorubicin as first-line systemic chemotherapy in patients with inoperable hepatocellular carcinoma, Cancer Chemotherapy and Pharmacology, 2009, 63, 5, 929

    CrossRef

37. 37
    J. O. Lee, K. W. Lee, D. Y. Oh, J. H. Kim, S. A. Im, T. Y. Kim, Y. J. Bang, Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma, Annals of Oncology, 2009, 20, 8, 1402

    CrossRef

38. 38
    Ju Hyun Shim, Joong-Won Park, Byung Ho Nam, Woo Jin Lee, Chang-Min Kim, Efficacy of combination chemotherapy with capecitabine plus cisplatin in patients with unresectable hepatocellular carcinoma, Cancer Chemotherapy and Pharmacology, 2009, 63, 3, 459

    CrossRef

39. 39
    Melanie Thomas, Molecular targeted therapy for hepatocellular carcinoma, Journal of Gastroenterology, 2009, 44, S19, 136

    CrossRef

40. 40
    Niraj J. Gusani, Yixing Jiang, Eric T. Kimchi, Kevin F. Staveley-OʼCarroll, Hua Cheng, Jaffer A. Ajani, New Pharmacological Developments in the Treatment of Hepatocellular Cancer, Drugs, 2009, 69, 18, 2533

    CrossRef

41. 41
    Jeong-Ok Lee, Dae-Young Kim, Joo Han Lim, Myung-Deok Seo, Hyeon Gyu Yi, Do-Youn Oh, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang, Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation, Journal of Gastroenterology and Hepatology, 2009, 24, 5

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(181K)
    • References
42. 42
    Susana Oquiñena, Mercedes Iñarrairaegui, Juan J. Vila, Felix Alegre, Jose M. Zozaya, Bruno Sangro, Spontaneous Regression of Hepatocellular Carcinoma: Three Case Reports and a Categorized Review of the Literature, Digestive Diseases and Sciences, 2009, 54, 5, 1147

    CrossRef

43. 43
    Won Kim, Jung-Hwan Yoon, Jung-Ryul Kim, In-Jin Jang, Yung-Jue Bang, Yoon-Jun Kim, Hyo-Suk Lee, Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma, Cancer Chemotherapy and Pharmacology, 2009, 64, 3, 497

    CrossRef

44. 44
    Ahmed O. Kaseb, Amr Hanbali, Matthew Cotant, Manal M. Hassan, Ira Wollner, Philip A. Philip, Vascular endothelial growth factor in the management of hepatocellular carcinoma, Cancer, 2009, 115, 21

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(215K)
    • References
45. 45
    Ahmed Kaseb, Melanie Thomas, Hepatocellular Carcinoma, 2009,

    CrossRef

46. 46
    Amani Asnacios, Laetitia Fartoux, Olivier Romano, Chloe Tesmoingt, Samy Louafi S, Touraj Mansoubakht, Pascal Artru, Thierry Poynard, Olivier Rosmorduc, Mohamed Hebbar, Julien Taieb, Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma, Cancer, 2008, 112, 12

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(95K)
    • References
47. 47
    Natasha Walzer, Laura M Kulik, Hepatocellular carcinoma: latest developments, Current Opinion in Gastroenterology, 2008, 24, 3, 312

    CrossRef

48. 48
    Ronald Koschny, Carsten Grüllich, Tom Michael Ganten, Standards und neue Aspekte der Diagnostik und Therapie des hepatozellulären Karzinoms, Onkopipeline, 2008, 1, 3, 109

    CrossRef

49. 49
    L. Costes, M. Ducreux, V. Boige, Traitement systémique du carcinome hépatocellulaire, Oncologie, 2008, 10, 3, 191

    CrossRef

50. 50
    V Boige, J-L Raoul, J-P Pignon, O Bouché, J-F Blanc, L Dahan, J-L Jouve, N Dupouy, M Ducreux, Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial, British Journal of Cancer, 2007,

    CrossRef

51. 51
    Daniel H. Palmer, Matthew E. Cramp, Systemic Therapy for Hepatocellular Carcinoma: Future Directions,

    Direct Link:

    • Summary
    • PDF(149K)
    • References